Senti Biosciences Subsidiary Issues $10M Convertible Notes

Senti Holdings, a wholly owned subsidiary of Senti Biosciences Holdings, Inc., issued and sold $10.0 million in aggregate principal amount of Senior Secured Convertible Notes to Celadon Partners SPV 24 on May 20, 2026. This transaction was pursuant to a previously announced Securities Purchase Agreement. In connection with the notes, the company also entered into a Registration Rights Agreement, a Guarantee, and Voting Agreements, and appointed Acquiom Agency Services LLC as collateral agent. The filing also alludes to a potential future merger with a Celadon affiliate and a contingent value right for stockholders, potentially worth up to $60.0 million tied to SENTI-202 milestones.